Cancer Screening Guidelines

A 47-year-old woman asks whether a mammogram is due. A 50-year-old man asks about a colonoscopy. A 30-year-old woman asks about a Pap smear. The NCLEX expects you to know the answer to all three — cold.

Cancer screening guidelines are among the most heavily tested community health topics on the NCLEX. The nurse must know current USPSTF and ACS recommendations. Breast cancer: mammography every 1-2 years starting at age 40 (ACS recommends annual from 40-44 with the option, annual from 45-54, then biennial from 55 onward; USPSTF recommends biennial from 40-74). Higher-risk individuals (BRCA mutation, first-degree relative with breast cancer, prior chest radiation) may need earlier screening and MRI. Cervical cancer: for ages 21-29, Pap smear alone every 3 years. For ages 30-65, three options are acceptable: Pap smear alone every 3 years, primary high-risk HPV (hrHPV) testing every 5 years, or Pap plus HPV co-testing every 5 years. Screening stops at age 65 if prior results were consistently normal. HPV vaccination does NOT eliminate the need for screening. Colorectal cancer: screening begins at age 45 for average-risk individuals (previously 50; updated by USPSTF and ACS). Options include colonoscopy every 10 years, FIT (fecal immunochemical test) annually, FIT-DNA (Cologuard) every 1-3 years, or flexible sigmoidoscopy every 5 years. Lung cancer: annual low-dose CT scan for adults aged 50-80 who have a 20 pack-year smoking history and currently smoke or quit within the past 15 years. Prostate cancer: the USPSTF recommends shared decision-making about PSA screening for men aged 55-69; PSA testing is NOT universally recommended, and the USPSTF recommends against screening men 70 and older. The ACS and AUA suggest earlier discussions (ages 40-45) for high-risk men including Black men and those with a family history of prostate cancer — these are not USPSTF recommendations but may appear as valid alternatives on the NCLEX. The community health nurse's role is educating patients about which screenings apply to them based on age and risk factors, addressing barriers to screening (cost, transportation, fear, cultural beliefs), and ensuring follow-up on abnormal results.

Key Distinctions

USPSTF and ACS recommendations sometimes differ — the NCLEX typically tests the USPSTF guidelines but may present ACS recommendations as valid alternatives. Students forget that cervical cancer screening starts at 21 regardless of sexual activity onset, and that it stops at 65 with adequate prior screening. The most common error is confusing screening intervals: Pap every 3 years, mammography every 1-2 years, colonoscopy every 10 years. Lung cancer screening requires BOTH age criteria AND pack-year criteria — neither alone qualifies. PSA screening for prostate cancer is a shared decision, not a universal recommendation.

Clinical Pearl

Screening ages in one sentence: Pap at 21, mammogram at 40, colonoscopy at 45, lung CT for 20-pack-year smokers at 50. When in doubt, the NCLEX answer is 'discuss screening options with the patient' — shared decision-making is always safe.